Decatenation checkpoint deficiency in stem and progenitor cells
- 31 December 2005
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 8 (6), 479-484
- https://doi.org/10.1016/j.ccr.2005.11.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cell Cycle Checkpoint Function in Bladder CancerJNCI Journal of the National Cancer Institute, 2003
- Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitorsGenes & Development, 2003
- ATR Enforces the Topoisomerase II-dependent G2 Checkpoint through Inhibition of Plk1 KinasePublished by Elsevier BV ,2002
- Embryonic stem cells and somatic cells differ in mutation frequency and typeProceedings of the National Academy of Sciences of the United States of America, 2002
- The human decatenation checkpointProceedings of the National Academy of Sciences of the United States of America, 2001
- Catalytic inhibitors of DNA topoisomerase IIBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Creation of monosomic derivatives of human cultured cell linesProceedings of the National Academy of Sciences of the United States of America, 1998
- ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damageCurrent Biology, 1998
- A topoisomerase II-dependent G2 cycle checkpoint in mammalian cellsNature, 1994
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969